Research article Special Issues

Evaluation and Characterization of Biodiesels Obtained Through Ethylic or Methylic Transesterification of Tryacylglicerides in Corn Oil

  • Received: 18 April 2014 Accepted: 04 June 2014 Published: 09 June 2014
  • This work was devoted to the transesterification of corn oil either with methyl or ethyl alcohol and to the characterization of the biodiesels (composed by FAME—fatty acid methyl esters—or FAEE—fatty acid ethyl esters, respectively) produced. As an initial hypothesis, it was argued whether or not the two alcohols, both with short molecular chains, would impart significant differences to the chemical characteristics of the two biodiesels from corn oil. The most common properties of the biodiesels were evaluated by determining corresponding parameters for acid value, peroxide value, water content, oxidative stability, free and total glycerin, kinematic viscosity at 40 ℃ and density at 20 ℃, for both chemical routes, FAME and FAEE. In general, values were found to be well within the recommended limits for commercial biodiesel, in accordance with the Brazilian, European and American standard recommendations, except only for the oxidative stability. The methyl biodiesel presented acidity of 0.08 mg KOH/g; peroxide index, 23.77 meq/kg; oxidation stability, 3.10 h; water content, 297.1 mg/kg; total glycerin, 0.092 %; free glycerin, 0.009 %; viscosity, 4.05 mm2/s and density, 878.7 kg/m. The methyl biodiesel presented acidity of 0.11 mg/ KOH; peroxide index, 22.39 meq/kg; oxidation stability, 2.13 h; water content, 264.8 mg/kg; total glycerin, 0.25 %; free glycerin, 0.02 %; viscosity, 4.37 mm2/s and density, 874.0 kg/m. From a direct inspection of chemical data for the two products prepared via the two chemical routes, it can be drawn that values of the physical and chemical parameters for both, methyl and ethyl biodiesels, are essentially similar, except for the oxidative stability. However, the oxidative stability can be suitably adjusted by adding an anti-oxidizing agent to the ethyl biodiesel medium. The two biodiesels are thus promising alternatives to fully replace or to be admixed to the mineral diesel. Relatively to the pure petrol diesel, the resulting admixture would clearly gain towards preserving the natural environment by reducing the emission of harmful gases that would also direct and significantly affect the human health.

    Citation: Douglas Queiroz Santos, Ana Paula de Lima, Maíra Martins Franco, David Maikel Fernandes, Waldomiro Borges Neto, José Domingos Fabris. Evaluation and Characterization of Biodiesels Obtained Through Ethylic or Methylic Transesterification of Tryacylglicerides in Corn Oil[J]. AIMS Energy, 2014, 2(2): 183-192. doi: 10.3934/energy.2014.2.183

    Related Papers:

    [1] Agustín Gabriel Yabo, Jean-Baptiste Caillau, Jean-Luc Gouzé . Optimal bacterial resource allocation: metabolite production in continuous bioreactors. Mathematical Biosciences and Engineering, 2020, 17(6): 7074-7100. doi: 10.3934/mbe.2020364
    [2] Shahab Shamshirband, Javad Hassannataj Joloudari, Sahar Khanjani Shirkharkolaie, Sanaz Mojrian, Fatemeh Rahmani, Seyedakbar Mostafavi, Zulkefli Mansor . Game theory and evolutionary optimization approaches applied to resource allocation problems in computing environments: A survey. Mathematical Biosciences and Engineering, 2021, 18(6): 9190-9232. doi: 10.3934/mbe.2021453
    [3] Zehan Liu, Daoxin Qiu, Shengqiang Liu . A two-group epidemic model with heterogeneity in cognitive effects. Mathematical Biosciences and Engineering, 2025, 22(5): 1109-1139. doi: 10.3934/mbe.2025040
    [4] Xuyin Wang, Weiguo Liu, Lu Li, Peizhen Zhao, Ruifeng Zhang . Resource dependent scheduling with truncated learning effects. Mathematical Biosciences and Engineering, 2022, 19(6): 5957-5967. doi: 10.3934/mbe.2022278
    [5] Yanpei Liu, Yunjing Zhu, Yanru Bin, Ningning Chen . Resources allocation optimization algorithm based on the comprehensive utility in edge computing applications. Mathematical Biosciences and Engineering, 2022, 19(9): 9147-9167. doi: 10.3934/mbe.2022425
    [6] Xinru Zhou, Xinmiao Rong, Meng Fan, Josué-Antonio Nescolarde-Selvaa . Stoichiometric modeling of aboveground-belowground interaction of herbaceous plant. Mathematical Biosciences and Engineering, 2019, 16(1): 25-55. doi: 10.3934/mbe.2019002
    [7] Semu Mitiku Kassa . Three-level global resource allocation model for HIV control: A hierarchical decision system approach. Mathematical Biosciences and Engineering, 2018, 15(1): 255-273. doi: 10.3934/mbe.2018011
    [8] Yafei Li, Yuxi Liu . Multi-airport system flight slot optimization method based on absolute fairness. Mathematical Biosciences and Engineering, 2023, 20(10): 17919-17948. doi: 10.3934/mbe.2023797
    [9] Ali Gharouni, Lin Wang . Modeling the spread of bed bug infestation and optimal resource allocation for disinfestation. Mathematical Biosciences and Engineering, 2016, 13(5): 969-980. doi: 10.3934/mbe.2016025
    [10] Yu Shen, Hecheng Li . A new differential evolution using a bilevel optimization model for solving generalized multi-point dynamic aggregation problems. Mathematical Biosciences and Engineering, 2023, 20(8): 13754-13776. doi: 10.3934/mbe.2023612
  • This work was devoted to the transesterification of corn oil either with methyl or ethyl alcohol and to the characterization of the biodiesels (composed by FAME—fatty acid methyl esters—or FAEE—fatty acid ethyl esters, respectively) produced. As an initial hypothesis, it was argued whether or not the two alcohols, both with short molecular chains, would impart significant differences to the chemical characteristics of the two biodiesels from corn oil. The most common properties of the biodiesels were evaluated by determining corresponding parameters for acid value, peroxide value, water content, oxidative stability, free and total glycerin, kinematic viscosity at 40 ℃ and density at 20 ℃, for both chemical routes, FAME and FAEE. In general, values were found to be well within the recommended limits for commercial biodiesel, in accordance with the Brazilian, European and American standard recommendations, except only for the oxidative stability. The methyl biodiesel presented acidity of 0.08 mg KOH/g; peroxide index, 23.77 meq/kg; oxidation stability, 3.10 h; water content, 297.1 mg/kg; total glycerin, 0.092 %; free glycerin, 0.009 %; viscosity, 4.05 mm2/s and density, 878.7 kg/m. The methyl biodiesel presented acidity of 0.11 mg/ KOH; peroxide index, 22.39 meq/kg; oxidation stability, 2.13 h; water content, 264.8 mg/kg; total glycerin, 0.25 %; free glycerin, 0.02 %; viscosity, 4.37 mm2/s and density, 874.0 kg/m. From a direct inspection of chemical data for the two products prepared via the two chemical routes, it can be drawn that values of the physical and chemical parameters for both, methyl and ethyl biodiesels, are essentially similar, except for the oxidative stability. However, the oxidative stability can be suitably adjusted by adding an anti-oxidizing agent to the ethyl biodiesel medium. The two biodiesels are thus promising alternatives to fully replace or to be admixed to the mineral diesel. Relatively to the pure petrol diesel, the resulting admixture would clearly gain towards preserving the natural environment by reducing the emission of harmful gases that would also direct and significantly affect the human health.


    Hepatitis C is a liver inflammatory disease caused by a viral infection. Hepatitis C virus (HCV) is an RNA-type virus from the Flaviviridae family (genus Hepacivirus) which has a high replication rate. Hepatitis can develop into liver cancer [1] and can cause serious complications even death [2,3]. Around 60 – 85% of acute hepatitis C may develop into a chronic condition, 10–15% may develop cirrhosis, and 25% may develop liver cancer [1,2,4]. It is estimated that 58 million people have a chronic hepatitis C, with 1.5 million new infections occurring per year over the world[5]. There is no vaccine available for HCV [3,4,6,7], thus it is important to gain a better insight into the nature of this disease.

    One of the accurate tools to understand the dynamics of hepatitis C is using a mathematical model. There are several mathematical models developed for HCV for example in [8,9] studying the HCV model in population level. The HCV model incorporating treatment, therapy, or isolation were investigated in [10,11,12,13,14]. In reference [15], the optimal control strategies for HCV epidemics considering the uncertainty of the model was discussed.

    The spread of HCV at the cellular level was also investigated by several researchers e.g., [16,17,18,19,20]. In 1998, Neumann et al. studied the dynamic of HCV and the effect of antiviral. They have found that HCV is highly dynamic. An existing deterministic model cannot be applied to describe randomness in many biological factors, for instance, the random occurrence of cell infection, mutation, and apoptosis [21,22]. Furthermore, during the spread of HCV, different cells and infectious virus particles reacting in the same environment can give different effects. In other words, some uncertain factors influence the spread of HCV in body cells such as lifestyle (alcohol consumption or smoking), patient compliance level, lipid metabolism, metabolic syndrome, and body weight [23]. Motivated by this phenomenon, we are interested in extending the mathematical model given in [24] by considering uncertainty factors. A stochastic model will be derived from the deterministic model. This model provides better insight into the uncertainty and variability of the disease dynamic. Moreover, the solution of the stochastic model is in the form of distribution[25], while the solution of the deterministic model only produces one predictive value [26]. Several papers also discussed the stochastic HCV model, e.g., [27,28,29,30,31,32]. In contrast, in this paper, the noise parameter is added in the transmission rate representing the characteristic of variability and the treatment in the model is considered.

    The outline of this paper is organized as follows. In Section 2, the HCV model involving stochastic disturbances in the transmission rate are developed. In addition, the existence, uniqueness, and boundedness of the solution are established. In Section 3, we derive the extinction and persistence in mean condition. In Section 4, the numerical simulations are carried out to illustrate the analytical results. The conclusions are presented in the last section.

    Recall a deterministic mathematical model of HCV given in [24] as

    $ dTdt=Λδ1T(1η)βVTdIdt=(1η)βVTδ2IdVdt=(1ϵ)kIcV.
    $
    (2.1)

    where $ T $ is the number of uninfected cells, $ I $ is the number of infected cells, and $ V $ is the number of free viruses. The uninfected cells are produced at rate $ \Lambda $ and die naturally at a constant rate $ \delta_1 $. Cells become infected when they are interacting with a virus with a constant rate $ \beta $, and once infected, they will die at a constant rate $ \delta_2 $. HCV is produced by infected cells at a constant rate $ k $ and cleared at a constant rate $ c $.

    For the deterministic model $ (2.1) $, the disease-free equilibrium point is $ E_{0} = \left(\frac{\Lambda}{\delta_{1}}, 0, 0\right) $ and the endemic equilibrium point is $ E_{1} = \left(\frac{\delta_{2}c}{(1-\eta)(1-\epsilon)k\beta}, \frac{\Lambda}{\delta_{2}}-\frac{\delta_{1}c}{(1-\eta)(1-\epsilon)k\beta}, \frac{(1-\epsilon)k\Lambda}{\delta_{2}c}-\frac{\delta_{1}}{(1-\eta)\beta}\right). $ Using the next-generation matrix method [33], the basic reproduction number of the system $ (2.1) $ is $ R_{0}^{d} = \frac{(1- \epsilon)(1-\eta)\beta k \Lambda}{c \delta_{1} \delta_{2}} $.

    In this paper, we generalize system (2.1) by incorporating a stochastic noise parameter in the transmission rate as

    $ {dT=(Λδ1T(1η)βVT)dtσ(1η)VTdB(t)dI=((1η)βVTδ2I)dt+σ(1η)VTdB(t)dV=((1ϵ)kIcV)dt
    $
    (2.2)

    where $ B(t) $ is a standard Brownian motion and $ \sigma $ is a real constant which is known as the intensity of noise. The value $ \sigma $ is the standard deviation of transmission rate data that represents the variability of the transmission rate. The other description of parameters model (2.2) is given in Table 1. Clearly, the system (2.1) is the special case of the system (2.2), where $ \sigma = 0. $

    Table 1.  Variables and parameters of the model.
    Variable/Parameter Description Unit Range
    $ T(t) $ concentration of uninfected liver cells cell/mL $ \geq0 $
    $ I(t) $ concentration of infected liver cells cell/mL $ \geq0 $
    $ V(t) $ concentration of free viruses virion/mL $ \geq0 $
    $ \Lambda $ rate of production cell/day$ \times $mL $ \geq0 $
    $ \eta $ the effectiveness of drug in stopping infection [0, 1]
    $ k $ rate of free virus production virion/cell$ \times $day $ \geq0 $
    $ \epsilon $ the effectiveness of drug in blocking virus [0, 1]
    $ \beta $ transmission rate mL/virion $ \times $ day $ \geq0 $
    $ \delta_{1} $ death rate of uninfected liver cells 1/day $ \geq0 $
    $ \delta_{2} $ death rate of infected liver cells 1/day $ \geq0 $
    $ c $ virion clearance 1/day $ \geq0 $

     | Show Table
    DownLoad: CSV

    In this section, the theorem of the existence, uniqueness, and boundedness of the solution system $ (2.2) $ are established. Let $ (\Omega, \mathcal{F}, P) $ be a complete probability space with a filtration $ \left\{\mathcal{F}_t\right\}_{t\geq 0} $ satisfying the conditions that it is right continuous and $ \mathcal{F}_0 $ contains all P-null sets.

    Definition 2.1. [34]

    Let $ T > 0 $, $ F(., .):[0, T]\times \mathbb{R}^n \rightarrow \mathbb{R}^n, G(., .):[0, T]\times \mathbb{R}^n \rightarrow \mathbb{R}^{n\times m} $ be measurable function, and $ X(t) $ satisfy

    $ dX(t)=F(X(t))dt+G(X(t))dB(t),
    $
    (2.3)

    where F(., .) and G(., .) are the coefficients of (2.3). Then the coefficients (2.3) are locally Lipschitz, if

    $ |F(t,X)F(t,ˉX)|+|G(t,X)G(t,ˉX)|C1|XˉX|;X,ˉXRn,t[0,T],
    $
    (2.4)

    for some constant $ C_{1}\geq 0 $.

    Definition 2.2. [34]

    The coefficients of (2.3) satisfy linear growth condition, if

    $ |F(t,X)|+|G(t,X)|C2(1+|X|);XRn,t[0,T],
    $
    (2.5)

    for some constant $ C_{2} $.

    Lemma 2.3. The system (2.2) with the initial condition in $ {\mathbb{R}}^3 _+ $ is uniformly ultimately bounded and belongs to the following closed and bounded positively invariant set

    $ Γ={(T,I,V)R3+|0<T+IΛμ,0<V(1ϵ)(kΛcμ)}R3+,
    $
    (2.6)

    for every $ t\geq 0. $

    Proof. Let $ a(t) $ be a function such that $ a(t)\le \Lambda $. We know that $ N(t) = T(t)+I(t) $ is the concentration of uninfected and infected cells at time $ t $. Take $ \mu = \min \{\delta _1, \delta _2 \} $, then

    $ dN=dT+dI,=(Λδ1Tδ2I)dt,dN(ΛμN)dt.
    $
    (2.7)

    Let $ dN = (a(t) - \mu N) dt $, it follows that

    $ dN=(a(t)μN)dt,dNdt+μN=a(t),
    $

    thus,

    $ N(t)=eμt(t0eμτa(τ)dτ+N0).
    $
    (2.8)

    Since $ a(t) \leq \Lambda $, we obtain

    $ Neμt(t0eμτΛdτ+N0),=Λμ+(N0Λμ)eμt.
    $
    (2.9)

    By taking a limit $ t \to \infty $ of Eq ($ 2.9 $), we get

    $ N(t)Λμ.
    $

    Analog with the technique for solving Eq (2.7), for $ V(0) = V_0 $ and $ I(t) < N(t) \leq \frac{\Lambda}{\mu } $, we get

    $ dV(t)=[(1ϵ)kIcV]dt,[(1ϵ)(kΛμ)cV]dt,
    $

    then

    $ V(t)(1ϵ)(kΛcμ)+(V0(1ϵ)(kΛμ))ect.
    $
    (2.10)

    If we take $ \mathop {\lim }\limits_{t \to \infty } V(t) $, then

    $ V(t)(1ϵ)(kΛcμ).
    $

    Since the right-hand side of Eq (2.2) satisfies the Lipschitz condition, the solution exists and unique on $ [0, b) $ for some $ b > 0 $. Assume that there exists $ t_{1} \in (0, b) $ such that $ V(t_{1}) = 0 $ and all other variables are positive on $ t_{1} \in (0, b) $. Therefore, for all $ t \in [0, t_{1}] $

    $ dV=((1ϵ)kIcV)dt,cVdt,
    $

    thus

    $ V(t1)C3ect1>0,whereC3positiveconstant.
    $
    (2.11)

    This is contradiction with $ V(t_{1}) = 0 $. Then $ V(t) > 0. $ Analoguely, we get $ I(t) > 0 $ and $ T(t) > 0. $ Therefore, we obtain that $ (T(t), I(t) \in \left(0, \frac{\Lambda}{\mu}\right) $ for all $ t \in [0, T] $ and $ 0 < V(t)\leq (1 - \varepsilon)\left({\frac{{k \Lambda}}{{c\mu }}} \right). $

    Next, we define the necessary condition that guarantees the existence and uniqueness of time-global solution of Eq (2.2).

    Theorem 2.4. Let the coefficients of the system ($ 2.2 $) satisfy the Lipschitz condition. Then for any initial value $ (T(0), I(0), V(0)) \in \Gamma $, there exists a unique time-global solution $ (T(t), I(t), V(t)) \in \Gamma \subset {\mathbb{R}}^3_+, t \ge 0 $ with probability $ 1 $.

    Proof. According to Definition 2.1, Definition 2.2, and Theorem 5.2.1 in [34], there exists a unique global solution. However, we have that the coefficients of the system ($ 2.2 $) only satisfy the Lipschitz condition [35], thus system ($ 2.2 $) has a unique local solution on $ t\in [0, \tau_e) $ for any initial value $ (T(0), I(0), V(0))\in \Gamma $ where $ \tau_e $ is the explosion time (i.e. the time when the solution tends to infinity). To guarantee the solution of system ($ 2.2 $) is a unique global solution, it is necessary to show that $ \tau_{e} = \infty $ [36,37].

    Let $ k_0 > 0 $ be sufficiently large such that every component of $ (T(0), I(0), V(0)) $ is in the interval $ \left[ {\frac{1}{{{k_0}}}, {k_0}} \right] $. For every $ k \ge k_0 $, we define the stopping time or the first passage time (i.e. first period when the stochastic process penetrates the barrier) as

    $ τk=inf{t[0,τe)|T(t)(1k,k),I(t)(1k,k)orV(t)(1k,k)}.
    $

    Throughout this paper, we set $ \inf \emptyset = \infty $. It is known that the lower bound of $ \mathbb{R} $ is an empty set and the largest infimum of the empty set is infinity. Since $ \tau_k $ is increasing as $ k \to \infty $, and

    $ τ0τ1τ2...τkτk+1...,
    $

    then it follows that

    $ τ=limkτk,
    $

    thus $ \tau_\infty \le \tau_e $ almost sure. Next, it is necessary to show

    $ limkτk=.
    $

    We will prove by contradiction. Suppose that $ P(\tau_\infty < \infty) < 1 $. If $ \tau_\infty < \infty $, then there exist $ T^* > 0 $ and $ \varepsilon \in (0, 1) $ such that $ P\left\{ {{\tau _k} \le T^*} \right\} > \varepsilon, \forall k \ge k_0 $. In this case, the proof technique analogue is to [37,38,39]. Define a function $ {C^{2, 1}}, Q:{[0, \infty) \times \mathbb{R}}_ + ^3 \to {{\mathbb{R}}_ + } $ where

    $ Q(T,I,V)=(T1lnT)+(I1lnI)+(V1lnV).
    $

    Since

    $ y-1-\ln y \geq 0, \forall y > 0, $

    then Q is a non-negative function. By using It$ \hat{o} $'s formula, we get

    $ dQ=Qtdt+QTdT+QIdI+QVdV+(12)(2QT2(dT)2)+(12)(2QI2(dI)2)+(12)(2V2(dV)2)+2QTIdTdI+2QTVdTdV+2QIVdIdV,=(11T){[Λδ1T(1η)βVT]dtσ(1η)VTdB(t)}+(11I){[(1η)βVTδ2I]dt+σ(1η)VTdB(t)}+(11V){[(1ϵ)kIcV]dt}+12(σVT)2(1η)2(1T2+1I2)(dB(t))2,{Λ+δ1+δ2+(1ϵ)kI+(1η)βV+c+12(σVT)2(1η)2(1T2+1I2)}dt+{σ(1η)VT(1T1I)}dB(t),Mdt+σ(1η)VT(1T1I)dB(t),
    $
    (2.12)

    where $ M $ is a positive constant. Integrating Eq (2.12) from $ 0 $ to $ {{\tau _k} \wedge T^*} $ yields

    $ Q(T(τkT),I(τkT),V(τkT))Q(T(0),I(0),V(0))Mt+τkT0σ(1η)VT(1T1I)dB(t).
    $
    (2.13)

    Taking the expectation of both sides in Eq (2.13) leads to

    $ E(Q(T(τkT),I(τkT),V(τkT)))E(Q(T(0),I(0),V(0)))+E(Mt)+E(τkT0σ(1η)VT(1T1I)dB(t)),
    $
    $ \le Q(T(0),I(0),V(0)) + Mt. $ (2.14)

    Define $ {\Omega _k} = \left\{ {{\tau _k} \le T^*} \right\} $ for any $ k \ge k_0 $. Then for every $ w\in \Omega_k $ there are components of $ Q\left({T({\tau _k} \wedge T^*), I({\tau _k} \wedge T^*), V({\tau _k} \wedge T^*)} \right) $ which are equal to either $ k $ or $ \frac{1}{k} $, thus

    $ Q(T(τkT),I(τkT),V(τkT))min{k1lnk,1k1ln(1k)}.
    $
    (2.15)

    Combining Eqs (2.14) and (2.15) yields

    $ Q(T(0),I(0),V(0))+MtE(Q(T(τkT,w),I(τkT,w),V(τkT,w))),=E(1Ωk(w).Q(T(τk,w),I(τk,w),V(τk,w))),P(Ωk)min{k1lnk,1k1ln(1k)},εmin{k1lnk,1k1ln(1k)},
    $
    (2.16)

    where $ {1_{{\Omega _k}}} $ is the indicator function. By taking a limit $ k \to \infty $ of Eq (2.16), we obtain

    $ =Q(T(0),I(0),V(0))+Mt<.
    $

    This is contradiction. We get $ \tau _\infty = \infty $ or $ P(\tau _\infty = \infty) = 1. $ Therefore, there exists a unique time-global solution $ (T(t), I(t), V(t)) \in\Gamma \subset {\mathbb{R}}^3_+, t \ge 0 $ with probability $ 1 $.

    In this section, the theorem of the extinction and persistence in the mean condition system (2.2) is derived.

    In this part, we investigate the almost surely exponential stability of the disease-free equilibrium point by using the suitable Lyapunov function and another technique of stochastic analysis.

    Lemma 3.1. If

    $ σ>β2(δ2(1ϵ)kc),
    $
    (3.1)

    the disease-free equilibrium point $ (T, I, V) = (\Lambda/\delta_{1}, 0, 0) $ is almost surely exponentially stable in $ \Gamma $.

    Proof. The technical proof of this theorem follows from [38,40]. Define a function $ Q = \ln (I+V) $. Using It$ \hat{o} $'s formula, we obtain

    $ dQ=Qtdt+QTdT+QIdI+QVdV+12[2QT2dTdT+2QI2dIdI+2QV2dVdV]+2QTIdTdI+2QTVdTdV+2QIVdIdV,=1I+V[((1η)βVTδ2I)dt+σ(1η)VTdB]+1I+V[(1ϵ)kIcV]dt+12[1I+V)2(σ2(1η)2(VT)2)dt],={(1η)βZδ2II+VcVI+V+(1ϵ)kII+V12σ2(1η)2Z2}dt+σ(1η)ZdB,
    $

    where $ Z = \frac{VT}{I+V}. $ Futhermore, we have

    $ dQ12σ2(1η)2[Zβδ2(1η)]2dt+β22σ2dt[δ2(1ϵ)kc]dt+σ(1η)ZdB,β22σ2dt[δ2(1ϵ)kc]dt+σ(1η)ZdB.
    $
    (3.2)

    Taking the integral of ($ 3.2 $) and dividing both sides by t and then computing the limit superior $ t\rightarrow \infty $ yield

    $ limtsup1tln(I(t)+V(t))limtsup1t{ln(I(0)+V(0))+β22σ2[δ2(1ϵ)kc]}+limtsupt01tσ(1η)ZdB.
    $
    (3.3)

    By the strong law of large number for Martingales [41], we have

    $ limtsupt01tσ(1η)ZdB=0.
    $
    (3.4)

    Thus, from Eqs (3.3) and (3.4), we obtain

    $ \lim \limits_{t \to \infty } \sup \frac{1}{t} \ln(I(t)+V(t)) \leq \lim \limits_{t \to \infty } \sup \frac{1}{t} \{\ln (I(0)+V(0)) +\\ \frac{\beta^{2}}{2\sigma^{2}} -[\delta_{2}-(1-\epsilon)k \wedge c] \} < 0. $

    By Lemma 3.1, if the noise is increasing and satisfies the condition (2.10) HCV will die out. However, in this study, we also get that a bounded variation of infection rate could also lead to extinction. This is presented in the following theorem.

    Theorem 3.2. Let $ (T(0), I(0), V(0)) \in \Gamma $ be the initial value of system (2.2) and $ (T(t), I(t), V(t)) \in \Gamma $ be the corresponding solution. If

    $ Rs0=(1ϵ)(1η)βkΛcδ1δ2[14cδ21δ22(1ϵ)2(1η)2k2Λ2σ2]=Rd0[14cδ21δ22(1ϵ)2(1η)2k2Λ2σ2]<1
    $

    and $ \sigma^{2} < \frac{4 \delta_{1} \delta_{2} \beta }{(1-\epsilon) (1- \eta) k \Lambda} $, then HCV will be extinct almost surely, i.e.,

    $ \mathop {\lim }\limits_{t \to \infty } {T(t)} = \frac{\Lambda}{\delta_{1}}, \mathop {\lim }\limits_{t \to \infty } {I(t)} = 0 , \mathop {\lim }\limits_{t \to \infty } {V(t)} = 0. $

    Proof. The proof technique follows from [38,40,42,43]. Consider the first equation of system (2.2), then we get

    $ T(t)T(0)=Λtt0(1η)βV(s)T(s)dst0δ1T(s)dst0σ(1η)V(s)T(s)dB(s),
    $

    or

    $ 1tt0T(s)ds=Λδ1(T(t)T(0))δ1t1δ1tt0(1η)βV(s)T(s)ds1δ1tt0σ(1η)V(s)T(s)dB(s).
    $

    For simplicity, we define an integrable function $ \langle X \rangle = \frac{1}{t} \int_0^t X(s) ds $, $ X(t)\in [0, +\infty) $, thus

    $ T=Λδ1(T(t)T(0))δ1t1δ1(1η)βVT1δ1tt0σ(1η)V(s)T(s)dB(s).
    $
    (3.5)

    Taking the limit of Eq ($ 3.5 $) as t tend to infinity, we obtain

    $ limtT=1δ1limt[Λ(T(t)T(0))t(1η)βVT1tt0σ(1η)V(s)T(s)dB(s)],1δ1limt[Λ1tt0σ(1η)V(s)T(s)dB(s)],Λδ1.
    $

    Next, define a function $ Q = \ln ((1- \epsilon)kI+ \delta_{2} V) $. Applying Ito's formula, we obtain

    $ dQ=Qtdt+QTdT+QIdI+QVdV+12[2QT2dTdT+2QI2dIdI+2QV2dVdV]+2QTIdTdI+2QTVdTdV+2QIVdIdV,=(1ϵ)k(1ϵ)kI+δ2V[((1η)βVTδ2I)dt+σ(1η)VTdB]+δ2(1ϵ)kI+δ2V[(1ϵ)kIcV]dt+12[1((1ϵ)kI+δ2V)2(1ϵ)2k2(σ2(1η)2(VT)2)dt],[(1ϵ)k(1η)βTδ2c12δ2212(1ϵ)2k2σ2(1η)2T2]dt+(1ϵ)k(1ϵ)kI+δ2Vσ(1η)VTdB.
    $
    (3.6)

    Integrating both sides of Eq ($ 3.6 $) from 0 to t yields

    $ ln((1ϵ)kI+δ2V)ln((1ϵ)kI(0)+δ2V(0))+(1ϵ)kδ2(1η)βt0T(s)dsct14δ22(1ϵ)2k2σ2(1η)2t0(T(s))2ds+t0(1ϵ)k(1ϵ)kI(s)+δ2V(s)σ(1η)VTdB(s).
    $
    (3.7)

    Dividing both sides of Eq ($ 3.7 $) by $ t $ and taking a limit superior for $ t \rightarrow 0 $, we get

    $ limtsup1tln((1ϵ)kI+δ2V)limtsup1t[ln((1ϵ)kI(0)+δ2V(0))+(1ϵ)kδ2(1η)βt0T(s)ds]climtsup14δ22(1ϵ)2k2σ2(1η)2t0(T(s))2ds+t0(1ϵ)k(1ϵ)kI(s)+δ2V(s)σ(1η)VTdB(s).
    $

    By the strong law of large number for Martingales [41],

    $ \lim \limits_{t \to \infty }\sup \frac{1}{t} \int_0^t \frac{(1- \epsilon)k}{(1- \epsilon)kI(s) + \delta_{2} V(s)} \sigma (1- \eta) VT dB(s) = 0, $

    we obtain

    $ limtsup1tln((1ϵ)kI+δ2V)(1ϵ)kδ1δ2(1η)βΛc14δ22(1ϵ)2k2σ2(1η)2(Λ)2(δ1)2,c{[(1ϵ)(1η)βkΛcδ1δ214cδ22δ21(1ϵ)2(1η)2k2Λ2σ2]1},c[Rs01]<0.
    $

    Thus, $ \mathop {\lim }\limits_{t \to \infty } {I(t)} = 0 $ and $ \mathop {\lim }\limits_{t \to \infty } {V(t)} = 0. $ In other words, HCV will be extinct.

    In this subsection, we give a sufficient condition to guarantee the persistence in the mean condition.

    Definition 3.3. [31,40,44]

    System (2.2) is said to be persistent in mean if

    $ \mathop {\lim \inf }\limits_{t \to \infty } \frac{1}{t}\int_{0}^{t} [I(s)+V(s)] ds > 0 $

    almost surely.

    Theorem 3.4. Let $ (T(0), I(0), V(0)) \in \Gamma $ be the initial value of system (2.2) and $ (T(t), I(t), V(t)) \in \Gamma $ be the corresponding solution. If

    $ Rs1=(1ϵ)(1η)βkΛcδ1δ2[12cδ21(1+δ2)2(1ϵ)2(1η)2k2Λ2σ2]=Rd0[12cδ21(1+δ2)2(1ϵ)2(1η)2k2Λ2σ2]>1,
    $

    then HCV will be persistent in mean, i.e.,

    $ \mathop {\lim \inf }\limits_{t \to \infty } \frac{1}{t} \int_{0}^{t}\{I(s)+V(s)\} ds \geq \frac{\delta_{2}/(\delta_{2} \vee c)}{(1-\eta)(1-\epsilon)\beta \Lambda k} [\delta_{1} c(R_{1}^{s}-1)]. $

    Proof. Analogue to the proof technique in [40] and [44]. Integrating the system ($ 2.2 $) yields

    $ T(t)T(0)+I(t)I(0)+V(t)V(0)=Λtδ1t0T(s)dsδ2t0I(s)ds+(1ϵ)kt0I(s)dsct0V(s)ds
    $
    (3.8)

    Dividing both sides Eq (3.8) by $ t $, we get

    $ T(t)T(0)t+I(t)I(0)t+V(t)V(0)t=Λδ1tt0T(s)dsδ2tt0I(s)ds+(1ϵ)ktt0I(s)dsctt0V(s)ds1tt0T(s)ds=Λδ1δ2δ1tt0I(s)ds+(1ϵ)kδ1tt0I(s)dscδ1tt0V(s)dsΦ
    $
    (3.9)

    where

    $ \Phi (t) = \frac{T(t) - T(0)}{t}+\frac{I(t)-I(0)}{t}+\frac{V(t)-V(0)}{t}. $

    Define a function $ Q = \ln [(1-\epsilon)k I(t) + (1+\delta_{2})V(t)]. $ Applying It$ \hat{o} $'s formula, we obtain

    $ dQ=(1ϵ)k[((1η)βVTδ2I)dt+σ(1η)VTdB](1ϵ)kI+(1+δ2)V+(1+δ2)((1ϵ)kIcV)dt(1ϵ)kI+(1+δ2V)+12[(1η)2(1ϵ)2k2σ2(VT)2[(1ϵ)kI+(1+δ2)V]2dt],((1ϵ)(1η)kβTδ2c12(1η)2(1ϵ)2k2σ2T2(1+δ2)2)dt+σ(1η)(1ϵ)kVTdB(1ϵ)kI+(1+δ2)V.
    $
    (3.10)

    Integrating Eq (3.10) from 0 to t and dividing both sides by t, we have

    $ 1tln[(1ϵ)kI(t)+(1+δ2)V(t)]1tln[(1ϵ)kI(0)+(1+δ2)V(0)+1tt0(1ϵ)(1η)kβT(s)dsδ2c1tt012(1η)2(1ϵ)2k2σ2T(s)2ds(1+δ2)2+1tt0σ(1η)(1ϵ)kV(s)T(s)dB(s)(1ϵ)kI+(1+δ2)V.
    $
    (3.11)

    According to Eqs (3.9) and (3.11), we get

    $ δ2δ1tt0I(s)ds+cδ1tt0V(s)dsδ2(1η)(1ϵ)βΛk[c(Rs11)Φ(t)Ψ(t)+M(t)]
    $
    (3.12)

    where

    $ Rs1=(1ϵ)(1η)βkΛcδ1δ2[12cδ21(1+δ2)2(1ϵ)2(1η)2k2Λ2σ2],Ψ(t)=1tln[(1ϵ)kI(0)+(1+δ2)V(0),M(t)=1tt0σ(1η)(1ϵ)kV(s)T(s)dB(s)(1ϵ)kI+(1+δ2)V.
    $

    Taking the limit inferior of Eq (3.12) as $ t \rightarrow 0 $ yields

    $ limtinfδ2δ1tt0I(s)ds+cδ1tt0V(s)dslimtinfδ2(1η)(1ϵ)βΛk[c(Rs11)],limtinf1t[t0I(s)ds+t0V(s)ds]limtinfδ2/(δ2c)(1η)(1ϵ)βΛk[δ1c(Rs11)].
    $

    This completes the proof.

    In this section, we carry out a numerical simulation in order to provide an interpretation of the solution. We use the Euler-Maruyama method to determine the solution of system (2.2). The discretization of system (2.2) is given as follows

    $ {Ti+1=Ti+(Λδ1Ti(1η)βViTi)Δtσ(1η)ViTiΔtζIi+1=Ii+((1η)βViTiδ2Ii)Δt+σ(1η)ViTiΔtζVi+1=Vi+((1ϵ)kIicVi)Δt
    $
    (4.1)

    where $ t\in [t_{0}, t_{N}], \Delta t = \frac{t_{N}-t_{0}}{N} $, and $ \zeta $ is normally distributed N(0, 1).

    Three simulations are conducted. The first simulation is deterministic system. The second simulation is to represent the solution of a stochastic model in the extinction condition. The third simulation is illustrating the solution of a stochastic model when Lemma 3.1 and Theorem 3.2 are violated. The parameters and initial values of the model in each simulation are given in Table 2.

    Table 2.  Values and parameters of the model.
    Sim.1 Sim.2 Sim.3 Unit Reference
    $ T(0) $ $ 10^{6} $ $ 10^{6} $ $ 10^{6} $ cell/mL [45]
    $ I(0) $ $ 10^{5} $ $ 10^{5} $ $ 10^{5} $ cell/mL [45]
    $ V(0) $ $ 10^{5} $ $ 10^{5} $ $ 10^{5} $ virion/mL [45]
    $ \Lambda $ $ 8\times10^{5} $ $ 8\times10^{5} $ $ 8\times10^{5} $ cell/day$ \times $mL [17]
    $ \eta $ 0.7 0.7 0.7 [17]
    $ k $ 0.9 0.2 0.9 virion/cell$ \times $day [17]
    $ \epsilon $ 0.75 0.75 0.75 [17]
    $ \beta $ $ 5.4\times10^{-8} $ $ 5.4\times10^{-8} $ $ 5.4\times10^{-7} $ mL/virion $ \times $ day [17]
    $ \delta_{1} $ 0.0047 0.1 0.0047 1/day [17,46]
    $ \delta_{2} $ 0.3 0.3 0.3 1/day [17]
    $ c $ 0.8 1 0.8 1/day [17]
    $ \sigma $ $ 4\times10^{-7} $ $ 9\times10^{-8} $

     | Show Table
    DownLoad: CSV

    Figure 1 shows the solution of a deterministic model ($ \sigma = 0 $) with $ R_{0}^{d} > 1 $. It can be seen that the solution is tend to the endemic equilibrium point $ E_{1} = (6.6\times 10^6, 2.6\times 10^6, 7\times 10^5) $ which means that HCV disease is persistent.

    Figure 1.  Simulation 1: a deterministic model of the system (2.1).

    Figure 2 illustrates the stochastic model with $ \sigma = 4\times 10^{-7} $ the condition

    $ \sigma = \sqrt{ 1.6\times10^{-13}} = 4\times10^{-7} > \frac{\beta}{\sqrt{2(\delta_{2}-(1-\epsilon)k \wedge c)}} = 0.76\times10^{-7} $

    and $ R_{0}^{s} < 1 $ where $ \sigma^{2} = 1.6\times10^{-13} < \frac{4 \delta_{1} \delta_{2} \beta }{(1-\epsilon) (1- \eta) k \Lambda} = 5.4\times 10^{-13} $ satisfies Lemma 3.1 and Theorem 3.2 respectively. More precisely, when the choosen parameters satisfy Lemma 3.1 and Theorem 3.2, the point $ E_{0} = (8\times 10^6, 0, 0) $ is almost exponentially stable. It can be seen from Figure 2 where the concentration of infected cells and free viruses go to zero. Therefore, HCV will go extinct almost surely.

    Figure 2.  Simulation 2: a stochastic model of the system (2.2) with $ \sigma = 4\times 10^{-7} $, 10 paths.

    Figure 3 describes the condition when basic reproduction number $ R_{0}^{s} = 0.0214 < 1 $ and $ \sigma^{2} = 4.9\times10^{-15} < \frac{4 \delta_{1} \delta_{2} \beta }{(1-\epsilon) (1- \eta) k \Lambda} = 5.4\times 10^{-13} $. This is satisfying Theorem 3.2 and violating Lemma 3.1. That figure shows a stochastic noise impact the disease extinction.

    Figure 3.  Simulation 2: a stochastic model of the system (2.2) with $ \sigma = 7\times 10^{-8} $, 10 paths.

    Figure 4 shows that if the intensity of the disturbance is smaller where $ \sigma^{2} = 8.1\times10^{-16} < 1.9\times10^{-12} $, thus Lemma 3.1 is violated. Taking the time interval [0,400] with 4000 points and 10 paths, it appears in Figure 4(a) that the concentration of uninfected cells rises to a peak around at t = 30 days, then drops sharply to around t = 45 days and then they rise slowly. The graphics in Figures 4(b), (c) show the concentration of infected cells and free virus after t = 50 days which tend to certain interval values. This shows that hepatitis C remains exist.

    Figure 4.  Simulation 3: a stochastic model of the system (2.2) with $ \sigma = 9\times 10^{-8} $, 10 paths.

    Figure 5 describes the condition of the HCV extinction when Lemma 3.1 is satisfied while Theorem 3.2 is violated. It can be seen that figures show the concentration of infected cells and free virus from initial value that tends to zero for a long period of time.

    Figure 5.  Simulation 3: a stochastic model of the system (2.2) with $ \beta = 2.5\times 10^{-8} $, 10 paths.

    Figure 6(a) shows the distribution value of uninfected cells in simulation 2 with a confidence interval of 95 %. After time $ t $ about 50 days the concentration of uninfected cells will go to a positive constant value ($ 8\times 10^6 $). From Figure 6(b), the simulation at t = 5 is more diverse than t = 10. After time $ t $ 20 days, the concentration of infected cells will go to zero. Figure 6(c) shows the free virus concentration at the time $ t $ from 3 to 15 days is in the certain interval value. After time $ t $ 20 days, the virus concentration will go to zero. Therefore, from simulation 2, it can be concluded that stochastic disturbances can affect the behavior of the spread of hepatitis C. When conditions are met according to Lemma 3.1 and Theorem 3.2, at a certain time t hepatitis C will disappear. Mathematically, in this case, the basic reproduction number in the extinction condition is less than one.

    Figure 6.  A stochastic model of the system (2.2) with confidence interval on simulation 2.

    Figure 7 shows the confidence intervals for simulation 3 where we reduced the sigma values while preserving the other parameter values. Figure 7(a) shows the concentration of uninfected cells will reach peaks around 23 to 30 days and then decline. After 75 days the concentration will move to a certain interval value. The green lines show the mean value of the simulations. Figures 7(b), (c) show that after 75 days, the concentration of infected cells and free virus lead to a certain positive number interval value with a confidence interval of approximately 95 %. In other words, hepatitis C disease will persist.

    Figure 7.  A stochastic model of the system (2.2) with confidence interval on simulation 2.

    Lastly, we conduct a simulation for persistence in mean condition where $ \beta = 5.4\times 10^{-7}, \delta_{1} = 0.0047, k = 1, c = 0.6, \sigma = 9 \times 10^{-8} $, and the rest of parameters and initial values state in Table 2. Figure 8 illustrates the solution of the stochastic model compared to the deterministic. Figure 9 shows the number of concentrations of healthy cells, infected cells, and free virus at a certain value which are more than zero. When $ t \geq 50 $, it appears that the concentrations of uninfected cells, infected cells and free viruses go to an equilibrium state. According to the numerical calculations, we obtain $ R_{1}^{s} > 1 $ and the endemic equilibrium point $ E_{1} = (T, I, V) = (4.4\times 10^6, 2.6\times10^6, 1.08\times 10^6) $. According to Theorem 3.4 hepatitis C remains to exist which are also depicted in Figure 9. Figure 10 describes the condition if the noise intensity is increasing, then the solution of model $ (2.2) $ will be strongly oscillating around the endemic equilibrium point of the model $ (2.1) $.

    Figure 8.  A stochastic model of the system (2.2) on persistence in mean simulation compared to a deterministic.
    Figure 9.  A stochastic model of the system (2.2) with $ \sigma = 9\times 10^{-8} $, 10 paths on simulation persistence in mean.
    Figure 10.  A stochastic model of the system (2.2) with $ \sigma = 2\times 10^{-7} $, 10 paths on simulation persistence in mean.

    Furthermore, in Figure 11, we generate a 95% confidence interval for $ t \in [0,400] $ with 4000 paths. Figure 11(a) describes the number of uninfected cells that tends to a consistent interval value after 75 days. Figure 11(b), (c) show the confidence intervals of infected liver cells and free viruses. In the time t span of 0 to 400 days the number of concentrations in a row increases to a peak around day 27 for infected cells and free viruses, then decreases. After 30 days, leading to a consistent value for infected cells from $ 1.9 \times 10 ^ 6 $ to $ 3.9 \times 10 ^ 6 $, and free viruses from $ 0.75 \times 10 ^ 6 $ to $ 1.5 \times 10 ^ 6 $.

    Figure 11.  A stochastic model of the system (2.2) with confidence interval on persistence in mean simulation.

    In this paper, we propose an epidemic model for HCV transmission at the cellular level incorporating statistical noise. The results extend the paper of Neumann, et.al.[24] in understanding the dynamics of a deterministic hepatitis C virus. Various types of Lyapunov functions are designed to study the persistence in mean conditions as well as the extinction of the stochastic system. Based on this model, there exists a unique time-global solution for any given positive initial value. In addition, numerical simulations are carried out to describe the solution behaviour of the model. We analyze that if the noise intensity is increasing, then the disease will go to extinction. If the basic reproduction number of the extinction condition is less than one, then hepatitis C will extinct. If the basic reproduction number of the persistence in the mean condition is more than one, then hepatitis C remains to exist. When the noise intensity increases, the solution will give a strong oscillation under the condition of persistence in the mean. It can provide some useful strategies for controlling the dynamics of that disease. In future research, we can consider an optimal control of the stochastic model for HCV, research on memory effect, and fractional derivatives [47]. Furthermore, it needs to investigate the stochastics noise for other parameters apart from infection rate. It is also important to consider a stochastic model for HCV transmission involving the response immune system.

    The first author thanks LPDP Indonesia for the financial support under the Doctoral Program Scholarship. The authors thanks to Department of Mathematics, Universitas Gadjah Mada (UGM) and Directorate for the Higher Education, Ministry of Research, Technology, and Higher Education of Indonesia for the Research Grant "Penelitian Disertasi Doktor (PDD)" UGM 2021 under grant no. 2261/UN1/DITLIT/DIT-LIT/PT/2021. The special thanks also for some colleagues for the discussions during the research.

    The authors declare that they have no competing financial interest or personal relationships that could have appeared to influence the work reported in this paper.

    [1] Oliveira CCF, Suarez PAZ, Santos WLP. (2008) Biodiesel: Possibilidades e Desafios. Quim Nova 28: 3-8. In Portuguese.
    [2] Anisuddin S, Hashar NA, Tahseen S. (2005) Prevention of oil spill pollution in seawater using locally available materials. Arab J Sc Eng 30: 143-152.
    [3] ITOPF The International Tanker Owners Pollution Federation Limited. London, 2014. Available from: http://www.itopf.com/.
    [4] Runge, CF, Senauer B. (2007) How biofuels could starve the poor. Foreign Aff 86: 41-46.
    [5] Sharma YC, Singh B, Upadhyay SN (2008) Advancements in development and characterization of biodiesel: A review. Fuel 87: 2355-2373. doi: 10.1016/j.fuel.2008.01.014
    [6] Benjumea P, Agudelo J, Agudelo A. (2008) Basic properties of palm oil biodiesel-diesel blends. Fuel 87: 2069-2075. doi: 10.1016/j.fuel.2007.11.004
    [7] Helwani Z, Othman MR, Aziz N, et al. (2009) Technologies for production of biodiesel focusing on green catalytic techniques: A review. Fuel Process Technol 90: 1502-1514. doi: 10.1016/j.fuproc.2009.07.016
    [8] Padula AD, Santos MS, Ferreira L, et al. (2012) The emergence of the biodiesel industry in Brazil: Current figure sand future prospects. Energ Policy 44: 395–405.
    [9] Lin YC, Tsai CH, Yang CR, et al. (2008) Effects on aerosol size distribution of polycyclic aromatic hydrocarbons from the heavy-duty diesel generator fueled with feedstock palm-biodiesel blends. Atmos Environ 42: 6679-6688. doi: 10.1016/j.atmosenv.2008.04.018
    [10] Bi Y, Ding D, Wang D. (2010) Low-melting-point biodiesel derived from corn oil via urea complexation. Bioresour Technol 101: 1220-1226. doi: 10.1016/j.biortech.2009.09.036
    [11] Quintella CM, Teixeira LSG, Korn MGA, et al. (2009) Cadeia do biodiesel da bancada à indústria: uma visão geral com prospecção de tarefas e oportunidades para P&D&I. Quím Nova 32: 793-808. In Portuguese.
    [12] Duarte AP, Carvalho CRL, Cavichioli JC. (2008) Densidade, teor de óleo e produtividade de grãos em híbridos de milho. Bragantia 67: 759-767. In Portuguese. doi: 10.1590/S0006-87052008000300026
    [13] Suarez PAZ, Santos ALF, Rodrigues JP, et al. (2009) Biocombustíveis a partir de óleos e gorduras: desafios tecnológicos para viabilizá-los. Quím Nova 32; 768-775. In Portuguese.
    [14] ASTM D664 Standard Test Method for Acid Number of Petroleum Products by Potentiometric Titration. West Conshohocken, 2003. Avaiable from: http://www.astm.org/Standards/D664.htm.
    [15] ANVISA National Agency of Vigilance. Brasília, 2014 Available from: http://portal.anvisa.gov.br/wps/portal/anvisa/home.
    [16] CSN EN 14112 Determination of Oxidation Stability. The European Standard, 2007. Available from:http://www.en-standard.eu/csn-en-14112-fat-and-oil-derivatives-fatty-acid-methyl-esters-fame-determination-of-oxidation-stability-accelerated-oxidation-test/.
    [17] Pisarello ML, Costa BD, Mendow G, et al. (2010) Esterification with ethanol to produce biodiesel from high acidity raw materials: Kinetic studies and analysis of secondary reactions. Fuel Process Techn 91: 1005–1014.
    [18] Lôbo IPF, Ferreira SLC, Cruz, RS. (2009) Biodiesel: Parâmetros de Qualidade e Métodos Analíticos. Quím Nova 32: 1596-1608.
    [19] Munoz RAA, Fernandes DM, Santos DQ, et al. (2012) Biodiesel: Production, Characterization, Metallic Corrosion and Analytical Methods for Contaminants. Available from: http://www.intechopen.com/books/biodiesel-feedstocks-production-and-applications/biodiesel-production-characterization-metallic-corrosion-and-novel-analytical-methods-for-contaminan.
    [20] ANP National Petroleum Agency. Brasilia, 2012. Available from: http://nxt.anp.gov.br/nxt/gateway.dll/leg/resolucoes_anp/2012/maio/ranp%2014%20-%202012.xmL.
    [21] Fernandes DM, Serqueira DS, Portela FM, et al. (2012) Preparation and characterization of methylic and ethylic biodiesel from cottonseed oil and effect of tert-butylhydroquinone on its oxidative stability. Fuel 97: 658-661. doi: 10.1016/j.fuel.2012.01.067
    [22] Velasco J, Andersen ML, Skibsted LH. (2004) Evaluation of oxidative stability of vegetable oils by monitoring the tendency to radical formation. A comparison of electron spin resonance spectroscopy with the Rancimat method and differential scanning calorimetry. Food Chem 85: 623-632.
    [23] Tan CP, Che YBM, Selamat J, et al. (2002) Comparative studies of oxidative stability of edible oils by differential scanning calorimetry and oxidative stability index methods. Food Chem 76: 385-389. doi: 10.1016/S0308-8146(01)00272-2
    [24] Dantas MB, Conceição M, Fernandes VJ, et al. (2007) Thermal and kinetic study of corn biodiesel obtained by the methanol and ethanol routes. J Therm Anal Calorim 87: 835-839. doi: 10.1007/s10973-006-7780-2
    [25] Dantas MB, Almeida AAF, Conceição M, et al. (2007) Characterization and kinetic compensation effect of corn biodiesel. J Therm Anal Calorim 87: 847-851. doi: 10.1007/s10973-006-7786-9
    [26] Lôbo IP, Ferreira SLC, Cruz RS. (2009) Biodiesel: parâmetros de qualidade e métodos analíticos. Quím Nova 32: 1596-1608.
    [27] Encinar JM, Sánchez N, Martínez G, et al. (2011) Study of biodiesel production from animal fats with high free fatty acid content. Bioresour Technol 102: 10907-10914. doi: 10.1016/j.biortech.2011.09.068
    [28] ABNT NBR 10441 Determination of Kinematic Viscosity and Calculation of Dynamic Viscosity. Brasília, 2007. Available from: http://www.abntcatalogo.com.br/norma.aspx?ID=001234.
    [29] Santos DQ. (2010) Transesterificação de milho e soja, análise quimiométrica do processo e caracterização das propriedades físico-químicas do produto. DSc Thesis at Federal University of Uberlândia, Brazil. 108p.
    [30] In Portuguese.Lima AL, Santos QD, Lima AP, et al. (2012) Thermal expansion coefficient and algebraic models to correct values of specific mass as a function of temperature for corn biodiesel. Fuel 106: 646-650.
  • Reader Comments
  • © 2014 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(5801) PDF downloads(1117) Cited by(7)

Figures and Tables

Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog